These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23505244)

  • 21. The tumour necrosis factor receptor-associated periodic syndrome: current concepts.
    Stojanov S; McDermott MF
    Expert Rev Mol Med; 2005 Oct; 7(22):1-18. PubMed ID: 16216134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and clinical spectrum of four pedigrees of TRAPS in Greece: results from a national referral center.
    Nezos A; Argyropoulou OD; Klinaki E; Marketos N; Karagianni P; Eliopoulos E; Vlachoyiannopoulos P; Maritsi DN; Tzioufas AG
    Rheumatology (Oxford); 2020 Jun; 59(6):1241-1246. PubMed ID: 31562507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Setting up TRAPS.
    Pettersson T; Kantonen J; Matikainen S; Repo H
    Ann Med; 2012 Mar; 44(2):109-18. PubMed ID: 21284532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of NLRP3, MVK and TNFRSF1A variants in adult Greek patients with autoinflammatory symptoms.
    Karagianni P; Nezos A; Ioakeim F; Tzioufas AG; Moutsopoulos HM
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):86-89. PubMed ID: 30418111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
    Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
    Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel TNFRSF1A gene mutation in a patient with tumor necrosis factor receptor-associated periodic syndrome.
    Khabazi A; Maralani M; Andalib S; Sakhinia E
    Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):175-177. PubMed ID: 27793577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome.
    Tsuji S; Matsuzaki H; Iseki M; Nagasu A; Hirano H; Ishihara K; Ueda N; Honda Y; Horiuchi T; Nishikomori R; Morita Y; Mukai T
    Clin Exp Immunol; 2019 Dec; 198(3):416-429. PubMed ID: 31429073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS).
    Negm OH; Mannsperger HA; McDermott EM; Drewe E; Powell RJ; Todd I; Fairclough LC; Tighe PJ
    Eur J Immunol; 2014 Jul; 44(7):2096-110. PubMed ID: 24668260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Israeli Arab patient with a de novo TNFRSF1A mutation causing tumor necrosis factor receptor-associated periodic syndrome.
    Aganna E; Zeharia A; Hitman GA; Basel-Vanagaite L; Allotey RA; Booth DR; Hawkins PN; Thacker C; Syndercombe-Court D; McDermott MF
    Arthritis Rheum; 2002 Jan; 46(1):245-9. PubMed ID: 11817598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family.
    Dodé C; Papo T; Fieschi C; Pêcheux C; Dion E; Picard F; Godeau P; Bienvenu J; Piette JC; Delpech M; Grateau G
    Arthritis Rheum; 2000 Jul; 43(7):1535-42. PubMed ID: 10902757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis.
    Sainz J; Salas-Alvarado I; López-Fernández E; Olmedo C; Comino A; García F; Blanco A; Gómez-Lopera S; Oyonarte S; Bueno P; Jurado M
    Int J Immunopathol Pharmacol; 2010; 23(2):423-36. PubMed ID: 20646338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes.
    Todd I; Radford PM; Daffa N; Bainbridge SE; Powell RJ; Tighe PJ
    Arthritis Rheum; 2007 Aug; 56(8):2765-73. PubMed ID: 17665435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First Case of TNF-Receptor-Associated Autoinflammatory Syndrome (TRAPS) in Bulgaria.
    Solakov PT
    Folia Med (Plovdiv); 2016 Sep; 58(3):211-214. PubMed ID: 27760004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TNF receptor-associated periodic fever syndrome caused by sequence alterations in exonic splicing enhancers: comment on the article by Trübenbach et al.
    Martorana D; Neri TM
    Rheumatol Int; 2010 Jul; 30(9):1269-71. PubMed ID: 19823838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.
    Simon A; Park H; Maddipati R; Lobito AA; Bulua AC; Jackson AJ; Chae JJ; Ettinger R; de Koning HD; Cruz AC; Kastner DL; Komarow H; Siegel RM
    Proc Natl Acad Sci U S A; 2010 May; 107(21):9801-6. PubMed ID: 20457915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profile in TNF receptor-associated periodic syndrome reveals constitutively enhanced pathways and new players in the underlying inflammation.
    Borghini S; Ferrera D; Prigione I; Fiore M; Ferraris C; Mirisola V; Amaro AA; Gueli I; Zammataro L; Gattorno M; Pfeffer U; Ceccherini I
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S121-S128. PubMed ID: 27310036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution.
    Haas SL; Lohse P; Schmitt WH; Hildenbrand R; Karaorman M; Singer MV; Böcker U
    Gastroenterology; 2006 Jan; 130(1):172-8. PubMed ID: 16401480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa.
    Stojanov S; Lohse P; Lohse P; Hoffmann F; Renner ED; Zellerer S; Kéry A; Shin YS; Haas D; Hoffmann GF; Belohradsky BH
    Arthritis Rheum; 2004 Jun; 50(6):1951-8. PubMed ID: 15188372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brief Report: Association of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome With Gonosomal Mosaicism of a Novel 24-Nucleotide TNFRSF1A Deletion.
    Rowczenio DM; Trojer H; Omoyinmi E; Aróstegui JI; Arakelov G; Mensa-Vilaro A; Baginska A; Silva Pilorz C; Wang G; Lane T; Brogan P; Hawkins PN; Lachmann HJ
    Arthritis Rheumatol; 2016 Aug; 68(8):2044-9. PubMed ID: 26992170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
    Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.